We are live on ! Find out more
Aviva

Aviva Portfolio holdings

AUM $59.6B
1-Year Est. Return 28.44%
This Fund
S&P 500
This Quarter Est. Return
+10.03%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$55B
AUM Growth
+$6.6B
Cap. Flow
+$2.65B
Cap. Flow %
4.81%
Top 10 Hldgs %
35.14%
Holding
929
New
47
Increased
589
Reduced
189
Closed
58

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$255M
2
AAPL icon
Apple
AAPL
+$173M
3
MSFT icon
Microsoft
MSFT
+$166M
4
JPM icon
JPMorgan Chase
JPM
+$134M
5
AMZN icon
Amazon
AMZN
+$101M

Top Sells

Rank Stock Value
1
OTIS icon
Otis Worldwide
OTIS
+$74.8M
2
ACN icon
Accenture
ACN
+$70.7M
3
ELV icon
Elevance Health
ELV
+$69.2M
4
HES
Hess
HES
+$59.9M
5
MSI icon
Motorola Solutions
MSI
+$53.7M

Sector Composition

Rank Sector Weight
1 Technology 34.07%
2 Financials 13.98%
3 Consumer Discretionary 10.82%
4 Communication Services 10.11%
5 Healthcare 8.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RMBS icon
651
Rambus
RMBS
$10.4B
$603K ﹤0.01%
5,786
-2,410
-29% -$186K
LAUR icon
652
Laureate Education
LAUR
$5.18B
$598K ﹤0.01%
18,953
-1,923
-9% -$50.4K
NFG icon
653
National Fuel Gas
NFG
$7.84B
$594K ﹤0.01%
+6,430
New +$561K
UI icon
654
Ubiquiti
UI
$31.8B
$588K ﹤0.01%
890
-281
-24% -$140K
RNR icon
655
RenaissanceRe
RNR
$13.7B
$578K ﹤0.01%
2,278
-1,631
-42% -$395K
IDR icon
656
Idaho Strategic Resources
IDR
$449M
$571K ﹤0.01%
+16,887
New +$399K
KRYS icon
657
Krystal Biotech
KRYS
$9.88B
$570K ﹤0.01%
3,231
-344
-10% -$51.5K
ORI icon
658
Old Republic International
ORI
$10.3B
$568K ﹤0.01%
13,381
+73
+0.5% +$2.82K
OVV icon
659
Ovintiv
OVV
$17.5B
$567K ﹤0.01%
+14,038
New +$573K
HIMS icon
660
Hims & Hers Health
HIMS
$6.5B
$566K ﹤0.01%
9,972
+2,009
+25% +$103K
URBN icon
661
Urban Outfitters
URBN
$5.99B
$564K ﹤0.01%
7,896
+131
+2% +$9.63K
UNM icon
662
Unum
UNM
$13.8B
$562K ﹤0.01%
7,222
+941
+15% +$70.5K
PPC icon
663
Pilgrim's Pride
PPC
$6.82B
$561K ﹤0.01%
13,784
+2,356
+21% +$107K
AIZ icon
664
Assurant
AIZ
$13.7B
$559K ﹤0.01%
2,579
+102
+4% +$20.7K
G icon
665
Genpact
G
$5.3B
$556K ﹤0.01%
13,282
+813
+7% +$35.7K
NTGR icon
666
NETGEAR
NTGR
$669M
$553K ﹤0.01%
+17,086
New +$467K
DBX icon
667
Dropbox
DBX
$6.81B
$553K ﹤0.01%
18,317
-254
-1% -$7.26K
ADT icon
668
ADT
ADT
$5.16B
$552K ﹤0.01%
63,423
+31,903
+101% +$274K
TMHC icon
669
Taylor Morrison
TMHC
$552K ﹤0.01%
8,356
-733
-8% -$48.2K
IDCC icon
670
InterDigital
IDCC
$6.68B
$548K ﹤0.01%
1,588
-2,877
-64% -$782K
UGI icon
671
UGI
UGI
$8B
$548K ﹤0.01%
16,475
+2,332
+16% +$81.5K
THG icon
672
Hanover Insurance
THG
$7.63B
$548K ﹤0.01%
3,016
+218
+8% +$37.4K
PRI icon
673
Primerica
PRI
$9.81B
$548K ﹤0.01%
1,973
+93
+5% +$25K
INGR icon
674
Ingredion
INGR
$6.38B
$548K ﹤0.01%
4,484
+769
+21% +$99.1K
AGX icon
675
Argan
AGX
$7.98B
$547K ﹤0.01%
2,026
-283
-12% -$64.8K

Similar funds

Aviva's Q3 2025 Portfolio in Review

As of Q3 2025, Aviva held 929 positions worth $55B, up 14% from $48.4B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Aviva deployed $2.65B of net new capital in Q3 2025, opening 47 new positions and adding to 589 existing holdings. Its largest new stake was Teva Pharmaceuticals: 1,123,553 shares worth $22.7M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 33% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Otis Worldwide, an estimated $74.8M trimmed.

  • Aviva's largest Q3 2025 buy was Teva Pharmaceuticals: 1,123,553 shares worth $22.7M.
  • Aviva added most to NVIDIA in Q3 2025, an estimated $255M increase.
  • Aviva's biggest Q3 2025 reduction was Otis Worldwide, cutting an estimated $74.8M.
  • Aviva fully exited Hess in Q3 2025, selling an estimated $59.9M.
  • Aviva's ten largest holdings make up 35% of its $55B portfolio in Q3 2025.
  • Aviva opened 47 new positions and closed 58 in Q3 2025.
  • Aviva's portfolio value rose 14% quarter-over-quarter to $55B.

Based on Aviva's 13F filing for Q3 2025, filed 13 Nov 2025.